Here is a highly interactive conference which will provide ample opportunity to interact with internationally renowned experts in the management of leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and benign hematologic malignancies !
Save the Dates !
The Physicians Education Resource, LLC (PER) conducting the 23rd Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas and Myeloma
Conference Location: Eden Roc Miami, 4525 Collins Avenue, Miami Beach, FL, 33140
Conference Dates: February 28th to March 3rd 2019
Deadline for submission is January 14, 2019, at 11:59 am EDT.
The 23rd, the annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma provides practitioners who manage hematologic malignancies the practical tools to translate emerging data into the best therapy for patients with these tumors, personalize care based upon patient and tumor characteristics, and apply novel management strategies to their practices to improve outcomes for their patients.
Back by popular demand! This 3.5-day meeting will be held from Thursday through mid-afternoon Sunday. As always, agenda topics will focus on methods to apply state-of-the-art strategies to your clinical practice settings. This engaging and highly interactive meeting will provide ample opportunity to interact with internationally renowned experts in the management of leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and benign hematologic malignancies. Our faculty will distill practice-changing evidence and recommend methods to place this information in its proper clinical context so it can be applied to the real-world care scenarios you encounter. In doing so, a focus will be placed on how to proactively mitigate and manage treatment-related toxicities associated with new treatment strategies.
The well-known and highly interactive Medical Crossfire® discussion panels interspersed throughout the meeting will allow attendees to explore some of the most challenging clinical situations in the management of hematologic malignancies, many of which have multiple potential approaches to care.
This dynamic Congress will challenge participants to apply new information they have learned, reflect on new practices they can bring back to their clinics to share with their peers, and ultimately improve patient outcomes in their practice settings.
This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.
- The expanding role of new immunologic approaches, including CAR T cells and checkpoint inhibitors, in hematologic malignancies
- The emergence of molecular-based therapies and new cytotoxic formulations in patients with acute leukemias
- Effective utilization of the increasing therapeutic armamentarium in multiple myeloma
- New clinical considerations for frontline and subsequent strategies for Hodgkin and non-Hodgkin lymphomas
- Patient, disease, and drug characteristics will inform sequencing decisions in patients with chronic lymphocytic leukemia
- New approaches for treatment and duration of therapy among patients with myeloproliferative neoplasms
|Nurses, PAs, Other Health Care Professionals